Apr 02, 2020
COVID-19 Pandemic in the US May Curtail Uptake of Recent Acute Migraine Market Entrants, Diminishing Specialists' Prelaunch Expectations that Biohaven's Nurtec ODT Would Challenge Allergan's Ubrelvy and Eli Lilly's Reyvow
Apr 02, 2020
China Gives Greenlight to Allergan's XEN® Registration for the Surgical Management of Refractory Glaucoma
Mar 31, 2020
Global Ocular Hypertension Pipeline Guide 2020
Mar 31, 2020
Allergan Earns ENERGY STAR® Partner of the Year - Sustained Excellence Award for the Seventh Consecutive Year
Mar 26, 2020
Allergan and Bausch Health Identified as the Top Companies Driving Therapeutic Innovation in IBS
Mar 25, 2020
Sosei Heptares Announces New Board Director Appointment and Executive Promotion
Mar 23, 2020
Insights into the Global Medical Aesthetic Market to 2024 - Trends, Forecast and Competitive Analysis
Mar 23, 2020
AbbVie Announces Extension of Expiration Date for Exchange Offers for Allergan Notes
Mar 18, 2020
Allergan Declares Second Quarter 2020 Cash Dividend of $0.74 Per Ordinary Share
Mar 17, 2020
AbbVie and Allergan Sign Consent Decree Agreement with Federal Trade Commission Staff on Pending Transaction
Mar 11, 2020
Kybella Injections for Treating Double Chin & Submental Fat in NYC with Dr. Michele Green
Mar 10, 2020
The global market of cosmetic surgery and procedure is evaluated to grow at a CAGR of 5.62% during the projected period, 2020-2028
Mar 10, 2020
Cytonus appoints Allergan executive Manisha Narasimhan, Ph.D. to its Board of Directors
Mar 09, 2020
AbbVie Announces Extension of Expiration Date for Exchange Offers for Allergan Notes
Mar 05, 2020
Allergan Receives FDA Approval for DURYSTA(TM) (bimatoprost implant) the First and Only Intracameral Biodegradable Sustained-Release Implant to lower Intraocular Pressure in Open-Angle Glaucoma or Ocular Hypertension Patients
Mar 03, 2020
AbbVie and Allergan Receive Final European Approval to Close Pending Transaction
Mar 02, 2020
Primmune Therapeutics Raises $7 Million Seed Financing to Develop Novel Oral TLR7 Immunotherapies for Cancer and Acute Viral Diseases
Mar 02, 2020
Primmune Therapeutics Raises $7 Million Seed Financing to Develop Novel Oral TLR7 Immunotherapies for Cancer and Acute Viral Diseases
Feb 25, 2020
eNeura, Inc. Announces Hire of Donald Pearl as Chief Executive Officer
Feb 25, 2020
Allergan to Present New Data for Investigational Bimatoprost Sustained-Release at American Glaucoma Society Annual Meeting